Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01025037 · ClinicalTrials.gov registry record · NA
Outcomes in Rotator Cuff Repair Using Graft Reinforcement
A NA study, sponsored by Stryker Trauma and Extremities.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT01025037: Completed NA study, sponsored by Stryker Trauma and Extremities.
NCT01025037 is a NA study that has completed, run by Stryker Trauma and Extremities. The registered enrollment target is 61 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01025037, a NA study, has completed, sponsored by Stryker Trauma and Extremities.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate patient shoulder functional outcomes following rotator cuff repairs reinforced with a surgical mesh.
Primary Outcome
The ASES evaluation generally has a patient self-evaluation section and a physician assessment section. The patient self-evaluation section of the form contains visual analog scales for pain, instability, an activities of daily living (ADL) questionnaire. The physician assessment section includes an area to collect demographic information and assesses range of motion, specific physical signs, strength, and stability. A shoulder score can be derived from the visual analogue scale score for pain (
Interventions
- DEVICE Conexa Reconstructive Tissue Matrix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2009-10 |
| Est. Completion | 2014-04 |
| Phase | NA |
What the finished NCT01025037 record still lists
NCT01025037 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Conexa Reconstructive Tissue Matrix is the first listed.
NCT01025037 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01025037 about?
NCT01025037 is a clinical study titled "Outcomes in Rotator Cuff Repair Using Graft Reinforcement". The purpose of this study is to evaluate patient shoulder functional outcomes following rotator cuff repairs reinforced with a surgical mesh.
What is the current status of trial NCT01025037?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2009-10. Estimated completion is 2014-04.
What interventions are being tested in trial NCT01025037?
The interventions under investigation include: Conexa Reconstructive Tissue Matrix (DEVICE).
Who is sponsoring clinical trial NCT01025037?
This trial is sponsored by Stryker Trauma and Extremities, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01025037's enrollment target sits among peer trials
61 1164th of 2000 higher than 837 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia